Fibrin patch (Ethicon/Omrix Biopharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFibrin patch (Ethicon/Omrix Biopharmaceuticals)
Drug Alias NameFibrin padFibrin sealant patchEvarrest
ClassificationBiologics > Blood components
Mechanisms of ActionProthrombin stimulants
TargetsProthrombin
Therapy Area/IndicationsBlood Loss, SurgicalHemorrhagePeripheral Vascular Diseases +[6] 
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2012/12/05
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesEthicon Inc
Inactive CompaniesOmrix BiopharmaceuticalsOmrix Biopharmaceuticals NvRush University Medical Center
Active IndicationsBlood Loss, SurgicalHemorrhage
Inactive IndicationsPeripheral Vascular DiseasesCardiovascular DiseasesGastrointestinal Diseases +[4] 

Other Information

ATC CodeB02BB01
Related LinksN/A